Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

Background: Interferon treatment, as an important approach of anti-tumor immunotherapy, has been implemented in multiple clinical trials of glioma. However, only a small number of gliomas benefit from it. Therefore, it is necessary to investigate the clinical role of interferons and to establish rob...

Full description

Bibliographic Details
Main Authors: Chen Zhu, Cunyi Zou, Gefei Guan, Qing Guo, Zihao Yan, Tianqi Liu, Shuai Shen, Xiaoyan Xu, Chen Chen, Zhiguo Lin, Wen Cheng, Anhua Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2019-09-01
Series:OncoImmunology
Subjects:
glioblastoma
interferon
prognosis
microenvironment
immune response
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1621677

Similar Items

Similar Items